EUVIMEDEUVIMED entdecken
Crossref

EPA-loaded silica nanoemulsions attenuate DEN-induced hepatic fibroinflammation by modulating homocysteine, PKCα/NF-κB, and Nrf2 signaling

Jihan Hussein, Sherien M El-Daly, Dalia Medhat, Mona A El-Bana, Safaa M Morsy, Enayat Omara, Hanan Elimam iD

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-026-05690-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Jihan Hussein und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Biochemistry Department, Medical Research and Clinical Studies Institute, National Research Centre, Giza, P.O. 12622, Egypt. jihan_husein@yah…. Hauptthemen laut MEDLINE: Silicon Dioxide, Eicosapentaenoic Acid, Anti-Inflammatory Agents, Liver Cirrhosis. Die Arbeit nennt 66 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatic fibroinflammation is a progressive pathological process characterized by persistent inflammation, oxidative stress, and extracellular matrix deposition, ultimately leading to liver fibrosis. Alterations in membrane fatty acid composition, particularly the imbalance between pro-inflammatory arachidonic acid (AA) and anti-inflammatory eicosapentaenoic acid (EPA), contribute significantly to disease progression. Despite the anti-inflammatory properties of EPA are well established, its clinical application is limited by poor bioavailability. Therefore, this study investigated the therapeutic efficacy and molecular mechanisms of an EPA-loaded silica nanoemulsion (EPA-NE) in a diethylnitrosamine (DEN)-induced rat model of hepatic fibroinflammation. Thirty-two male Wistar albino rats were randomly allocated into four groups: control, DEN-induced hepatic fibroinflammation, DEN + EPA, and DEN + EPA-NE. Biochemical, molecular, histopathological, and bioinformatic analyses were performed to evaluate treatment outcomes. Both EPA and EPA-NE significantly restored membrane EPA/AA homeostasis, increasing the EPA/AA ratio, and attenuated hepatic injury. EPA and EPA-NE reduced serum homocysteine levels by 57.4% and 72.3%, respectively, and suppressed NF-κB levels by 27.5% and 54.5%, respectively, compared with the DEN group (P < 0.0001). Moreover, EPA and EPA-NE enhanced antioxidant defenses, as evidenced by increased hepatic catalase activity by 1.7-fold and twofold, respectively, while reducing malondialdehyde levels by 23.1% and 46.2% (P < 0.0001), respectively. Molecular analyses demonstrated significant downregulation of PKCα expression and upregulation of Nrf2 and miR-34a expression, indicating attenuation of inflammatory and oxidative stress pathways. Histopathological examination further confirmed the marked reduction of hepatic fibroinflammatory alterations following treatment, with EPA-NE exhibiting superior efficacy compared with EPA. In conclusion, EPA-loaded silica nanoemulsion effectively attenuated DEN-induced hepatic fibroinflammation, restored fatty acid homeostasis, reduced homocysteine levels, and modulated molecular markers associated with oxidative stress and inflammation. These findings suggest that nanoemulsion-based delivery enhances the biological activity of EPA and support the potential of EPA-NE as a promising therapeutic strategy for hepatic fibroinflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Silicon DioxideEicosapentaenoic AcidAnti-Inflammatory AgentsLiver CirrhosisAnimalsMaleNF-E2-Related Factor 2NF-kappa BHomocysteineRats, WistarSignal TransductionProtein Kinase C-alphaEmulsionsRatsLiverNanoparticlesOxidative Stress

Stichwörter der Autor:innen

DEN modelEicosapentaenoic acidHomocysteineLiver fibroinflammationNanoemulsionNrf2PKCαmiR-34a

Substanzen

NF-E2-Related Factor 2NF-kappa BHomocysteineSilicon DioxideEicosapentaenoic AcidProtein Kinase C-alphaEmulsionsNfe2l2 protein, ratAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Medical Biochemistry Department, Medical Research and Clinical Studies Institute, National Research Centre, Giza, P.O. 12622, Egypt. jihan_husein@yahoo.com.
  • Medical Biochemistry Department, Medical Research and Clinical Studies Institute, National Research Centre, Giza, P.O. 12622, Egypt.
  • Cancer Biology and Genetics Laboratory, Centre of Excellence for Advanced Sciences, National Research Centre, Giza, P.O. 12622, Egypt.
  • Pathology Department, National Research Centre, Giza, P.O. 12622, Egypt.
  • Department of Biochemistry, Faculty of Pharmacy, University of Sadat City, Sadat City, 32897, Egypt. Hanan.Elimam@fop.usc.edu.eg.

ORCID-Profile: Hanan Elimam

Zitieren

APA

Hussein, J., El-Daly, S. M., Medhat, D., El-Bana, M. A., Morsy, S. M., Omara, E., & Elimam, H. (2026). EPA-loaded silica nanoemulsions attenuate DEN-induced hepatic fibroinflammation by modulating homocysteine, PKCα/NF-κB, and Nrf2 signaling. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05690-2

Vancouver

Hussein J, El-Daly SM, Medhat D, El-Bana MA, Morsy SM, Omara E, et al. EPA-loaded silica nanoemulsions attenuate DEN-induced hepatic fibroinflammation by modulating homocysteine, PKCα/NF-κB, and Nrf2 signaling. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05690-2

BibTeX
@article{Hussein2026,
  author = {Hussein, Jihan and El-Daly, Sherien M and Medhat, Dalia and El-Bana, Mona A and Morsy, Safaa M and Omara, Enayat and Elimam, Hanan},
  title = {EPA-loaded silica nanoemulsions attenuate DEN-induced hepatic fibroinflammation by modulating homocysteine, PKCα/NF-κB, and Nrf2 signaling},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-026-05690-2}
}
Kostenlos starten →